Jeb Keiper, M.S., M.B.A.

Jeb Keiper is the Chief Financial Officer & Chief Business Officer of Nimbus. Prior to joining Nimbus, Jeb was VP of Business Development for GlaxoSmithKline (GSK) Oncology and a member of the Oncology Executive team, and responsible for defining and executing the business development strategy for GSK Oncology, including in-licensing transactions, acquisitions, strategic alliances, academic research relationships, alliance management and competitive intelligence. Alongside these responsibilities, Jeb was also named to lead the GSK-Novartis integration of the commercial oncology business valued at $16B. Prior to GSK, Jeb worked in business development at TransForm Pharmaceuticals, as well as for McKinsey. He began his career at Pfizer as a chemist. He received four degrees from the Massachusetts Institute of Technology (MIT): one degree in Chemistry, two degrees in Chemical Engineering and an M.B.A. from the MIT Sloan School of Management.

location

130 Prospect Street, Suite 301
Cambridge, MA 02139
USA

call US

857-999-2009